Role of collagen type IV in the pathogenesis of increased prenasal thickness in Down syndrome fetuses: sonographic and immunohistological findings

References

[1] Down JLH. Observations on an ethnic classification of idiots. Clinical lectures and report. London Hospitals. 1866;3:259–62.Search in Google Scholar

[2] Snijders RJM, Noble PL, Sebire NJ, Souka A, Nicolaides KH. UK multicenter project on assessment of risk of trisomy 21 by maternal age and nuchal translucency thickness at 10–14 weeks of gestation. Lancet. 1998;352:343–6.10.1016/S0140-6736(97)11280-6Search in Google Scholar

[3] Benacerraf BR, Gelman R, Frigoletto FD Jr. Sonographic identification of second trimester fetuses with Down’s syndrome. N Engl J Med. 1987;317:1371–6.10.1056/NEJM198711263172203Search in Google Scholar PubMed

[4] Cicero S, Rembouskos G, Vandecruys H, Hogg M, Nicolaides KH. Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11–14-week scan. Ultrasound Obstet Gynecol. 2004;23:218–23.10.1002/uog.992Search in Google Scholar PubMed

[5] Bromley B, Lieberman E, Shipp TD, Benacerraf BR. Fetal nose bone length: a marker for Down syndrome in the second trimester. J Ultrasound Med. 2002;21:1387–94.10.7863/jum.2002.21.12.1387Search in Google Scholar PubMed

[6] Cicero S, Sonek JD, McKenna DS, Croom CS, Johns L, Nicolaides KH. Nasal bone hypoplasia in trisomy 21 at 15–22 weeks’ gestation. Ultrasound Obstet Gynecol. 2003;21:15–8.10.1002/uog.19Search in Google Scholar PubMed

[7] Bunduki V, Ruano R, Miguelez J, Yoshizaki CT, Kahhale S, Zugaib M. Fetal nasal bone length: reference range and clinical application in ultrasound screening for trisomy 21. Ultrasound Obstet Gynecol. 2003;21:156–60.10.1002/uog.31Search in Google Scholar PubMed

[8] Gamez F, Ferreiro P, Salmean JM. Ultrasonographic measurement of fetal nasal bone in a low-risk population at 19–22 gestational weeks. Ultrasound Obstet Gynecol. 2004;23:152–3.10.1002/uog.929Search in Google Scholar PubMed

[9] Maymon R, Levinsohn-Tavor O, Cuckle H, Tovbin Y, Dreazen E, Wiener Y, et al. Second trimester ultrasound prenasal thickness combined with nasal bone length: a new method of Down’s syndrome screening. Prenat Diagn. 2005;25:906–911.10.1002/pd.1207Search in Google Scholar PubMed

[10] Maymon R, Ushakov F, Waisman D, Cuckle H, Tovbin Y, Herman A. A model for second-trimester Down’s syndrome sonographic screening based on facial landmarks and digit length measurement. Ultrasound Obstet Gynecol. 2006;27:290–95.10.1002/uog.2619Search in Google Scholar PubMed

[11] Merker HJ. Morphology of the basement membrane. Microsc Res Tech. 1994;28:95–124.10.1002/jemt.1070280203Search in Google Scholar PubMed

[12] Poschl E, Schlotzer-Schrehardt U, Brachvogel B, Saito K, Ninomiya Y, Mayer U. Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development. 2004;131:1619–28.10.1242/dev.01037Search in Google Scholar

[13] Maymon R, Tovbin Y, Dreazen E, Weinraub Z, Herman A. All five digits of the hands of fetuses with Down syndrome are short. Ultrasound Obstet Gynecol. 2004;23:557–60.10.1002/uog.1074Search in Google Scholar

[14] Maymon R, Sharon M, Reish O, Schneider D, Halperin R, Herman A. Fetal abnormalities leading to termination of pregnancy: the experience at the Assaf Harofeh Medical Center between the years 1999–2000. Harefuah. 2003;142:405–9.Search in Google Scholar

[15] Tovbin J, Maymon R, Tovbin L, Dreazen E, Bukovsky I, Herman A. Prenatal age-specific reference intervals for measuring all five digits of the fetal hand. Ultrasound Obstet Gynecol. 2002;19:583–7.10.1046/j.1469-0705.2002.00628.xSearch in Google Scholar

[16] Maymon R, Moskovitch M, Levinsohn-Tavor O, Weinraub Z, Herman A, Cuckle H. Bedside estimation of Down’s syndrome risk from second-trimester ultrasound prenasal thickness. Ultrasound Obstet Gynecol. 2009;34:629–33.10.1002/uog.7480Search in Google Scholar

[17] Guis F, Ville Y, Vincent Y, Doumerc S, Pons JC, Frydman R. Ultrasound evaluation of the fetal nasal bone throughout gestation. Ultrasound Obstet Gynecol. 1995;5:304–7.10.1046/j.1469-0705.1995.05050304.xSearch in Google Scholar

[18] Halperin R, Vaknin Z, Ben-Ami I, Bukovsky I, Schneider D. Termination of multiple pregnancy at 18–24 weeks’ gestation by Laminaria dilatation and evacuation. J Reprod Med. 2004;49:357–60.Search in Google Scholar

[19] Halperin R, Zimmerman A, Langer R, Bukovsky I, Schneider D. Laminaria dilatation and evacuation for pregnancies with mid-trimester premature rupture of membranes: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol. 2002;10:181–4.10.1016/S0301-2115(01)00479-1Search in Google Scholar

[20] Maymon R, Jauniaux E, Moroz C. Enhanced expression of the immunoregulator, p43-placental isoferritin, in Down’s syndrome placentae and fetal kidneys. Mol Hum Reprod. 2002;8:1125–8.10.1093/molehr/8.12.1125Search in Google Scholar PubMed

[21] Van Agtmael T, Bruckner-Tuderman L. Basement membranes and human disease. Cell Tissue Res. 2010;339:167–88.10.1007/s00441-009-0866-ySearch in Google Scholar PubMed

[22] Cummings CF, Hudson BG. Lens capsule as a model to study type IV collagen. Connect Tissue Res. 2014;55:8–12.10.3109/03008207.2013.867337Search in Google Scholar PubMed PubMed Central

[23] Khoshnoodi J, Pedchenko V, Hudson BG. Mammalian collagen IV. Microsc Res Tech. 2008;71:357–70.10.1002/jemt.20564Search in Google Scholar PubMed PubMed Central

[24] von Kaisenberg CS, Krenn V, Ludwig M, Nicolaides KH, Brand-Saberi B. Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12–18 weeks and in a trisomy 16 mouse. Anat Embryol. 1998;197:105–24.10.1007/s004290050123Search in Google Scholar

[25] Brand-Saberi B, Floel H, Christ B, Schulte-Vallentin M, Schindler H. Alterations of the fetal extracellular matrix in the nuchal oedema of Down’s syndrome. Ann Anat. 1994;176:539–47.10.1016/S0940-9602(11)80391-2Search in Google Scholar

[26] Brand-Saberi B, Epperlein HH, Romanos GE, Christ B. Distribution of extracellular matrix components in nuchal skin from fetuses carrying trisomy 18 and trisomy 21. Cell Tissue Res. 1994;227:465–75.10.1007/BF00300219Search in Google Scholar

[27] von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH. Collagen type VI gene expression in the skin of trisomy 21 fetuses. Obstet Gynecol. 1998;91:319–23.10.1016/S0029-7844(97)00697-2Search in Google Scholar

[28] Bohlandt S, von Kaisenberg CS, Wewetzer K, Christ B, Nicolaides KH, Brand-Saberi B. Hyaluronan in the nuchal skin of chromosomally abnormal fetuses. Hum Reprod. 2000;15:1155–8.10.1093/humrep/15.5.1155Search in Google Scholar PubMed

[29] Miyabara S, Sugihara H, Maehara N, Shouno H, Tasaki H, Yoshida K, et al. Significance of cardiovascular malformations in cystic hygroma: a new interpretation of the pathogenesis. Am J Med Genet.1989;34:489–501.10.1002/ajmg.1320340408Search in Google Scholar PubMed

[30] Gittenberger-de Groot AC, Bartram U, Oosthoek PW, Bartelings MM, Hogers B, Poelmann RE, et al. Collagen type VI expression during cardiac development and in human fetuses with trisomy 21. Anat Rec A Discov Mol Cell Evol Biol. 2003;275:1109–16.10.1002/ar.a.10126Search in Google Scholar PubMed

[31] Wong SF, Ng WF, Ho LC. Histopathological findings of the nose of Down syndrome abortuses. Prenat Diagn. 2003;23:561–3.10.1002/pd.630Search in Google Scholar PubMed

[32] Minderer S, Gloning KP, Henrich W, Stöger H. The nasal bone in fetuses with trisomy 21: sonographic versus pathomorphological findings. Ultrasound Obstet Gynecol. 2003;22:16–21.10.1002/uog.160Search in Google Scholar PubMed